The role of caffeine
Everything seems to indicate that caffeine is not the only substance responsible. Klanzy team of Kaiser Permanent Medical Care Program, did not identify which component of coffee would be playing this protective role observed in his research.
In order to dispel this doubt, the Statistics Department Chair of Statistics in Medicine and Epidemiology, University of Milan-Bicocca, to evaluate the effects of consumption of different beverages containing caffeine on the risk of liver cirrhosis. Their findings suggest that coffee is the only filing this protective property and not tea or other beverages with caffeine.
As one of nature’s most consumed beverage around the world, coffee is a mixture of many chemicals, carbohydrates, lipids, amino acids, vitamins, minerals, alkaloids and other bioactive components such as caffeine, diterpenes and chlorogenic acid with antioxidant activity . The latter has been associated with caffeine to inhibit the generation of liver cancer in laboratory animals. Read the rest of this entry »
One or more components of coffee may reduce up to 22% risk of cirrhosis, study finds
Numerous investigations arising from the inverse relationship between coffee consumption and the development of liver cirrhosis. One of the most relevant in this regard has been done since the Divisions of Research and Gastroenterology, Department of Medicine, Kaiser Permanente Medical Care Program in Oakland (California).
Researchers say that one or more components of coffee that can reduce up to 22% the risk of serious liver disease. In fact, coffee drinkers in the family history cirrhosis have low levels of liver enzymes (transaminases), compared to those who do not drink coffee. Is caffeine responsible? Are there any other compound that produces this protective effect? Read the rest of this entry »
In the United States Dr. Burt Berkson MD, Dr. Whitaker MD, using the triple therapy for the treatment of liver disorders, poisoning and even slow aging.
The triple therapy uses the properties of alpha lipoic acid, silymarin from milk thistle, selenium.
Alpha lipoic acid: it is unusual to be both soluble and water soluble, allowing it to be particularly effective in the aqueous and lipid portions, and is used in virtually all body cells.
This particular one of the few able to cross the blood-brain barrier, it can be used very quickly by the brain tissue. Probably the only antioxidant to penetrate so easily into the brain. It can also regenerate vitamin E, vitamin C, glutathione and coenzyme Q10. It also has the ability to bind to heavy metals (eg mercury, cadmium, arsenic) it helps to remove the body and protects DNA from damage.
Dr. Berkson has used ALA successfully in cases of serious hepatitis, mushroom poisoning. You can also use it for heavy metal poisoning and counter the damage caused by radiation.
Researchers also believe that alpha lipoic acid can regenerate nerve cells and liver.
Milk Thistle: Silymarin is the active substance in the plant and providing a protective action of the liver against the deleterious effects of certain products. Silymarin has an action so strong that sometimes administered as an injection in the recovery rooms of hospitals, to counter the toxic effects on the liver of poisonous mushrooms.
Selenium: Selenium is a trace element involved in the fight of the body against free radicals. It is part of an antioxidant enzyme, glutathione peroxidase. Selenium much interest in the fight against cancer. A study published in 1996 in the Journal of the American Medical Association, showed that selenium supplementation protects the body against cancers of the lung, colon, rectum and prostate. Selenium participates in functions of detoxification of the body and helps it to fight against the effects of some heavy metals and toxic.
The recommended daily dose triple therapy is 600 mg of alpha lipoic acid, 900 mg of silymarin from milk thistle and 400 mcg of selenium. Take twice.
These therapies are offered to patients in the clinic of Dr. Berkson in Las Cruces, New Mexico and Dr. Whitaker Wellness Institute in California.